BUZZ-Centessa Pharma slips after launching share offering** U.S.-listed shares of Centessa Pharmaceuticals CNTA.O down 3.8% at $21.68 post-market as co looks to raise equity
** U.K.-based sleep disorder therapy developer commences offering of American depositary shares (ADSs); deal size not disclosed
** Jefferies, Leerink, Evercore and Guggenheim joint bookrunners
** CNTA has ~134.4 mln shares outstanding for $3 bln market cap
** Shares on Tues finished up 0.9% at $22.54, up 35% YTD
** All 15 analysts covering CNTA are bullish with median PT of $33, per LSEG data
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@thomsonreuters.commailto:lance.tupper@tr.com 1-646-279-6380))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.